DataString Consulting Company Logo
DataString Consulting Company Logo
13c Urea Market
Home»Recent Reports»13c Urea Market

13c Urea Market

Author: Vineet Pandey - Business Consultant, Report ID - DS1309071, Published - February 2025

Segmented in Product Type (Powder, Tablet), Application (Diagnostic Tests, Research Activities, Pharmaceutical Manufacturing, Others), End-User Sectors, Technology Platforms, Distribution Channels and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global 13c Urea Market Outlook

The market, for 13c urea was estimated at $422.5 million in 2024; and it is anticipated to increase to $585.9 million by 2030 with projections indicating a growth to around $769.4 million by 2035. This expansion represents a compound annual growth rate (CAGR) of 5.6% over the forecast period. The increasing popularity of 13C Urea highlights its growing importance in today's market scene. The continuous advancements in medicine play a role in driving this upward trend as 13C Urea is widely utilized for diagnostic purposes such as detecting Helicobacter pylori bacteria. Its continued significance stems from being non radioactive and non toxic making it a preferred option, for research and medical practices. Advancements in technology and the use of methods, with this substance are also helping expand its presence in the market.


13C Urea is an safe form of urea that is commonly used in the medical field due to its significance in conducting the Urea Breath Test (UBT). This test enables precise identification of stomach ulcers and various gastric issues triggered by H. pylori bacteria without being invasive in nature. The increasing occurrence of health problems along with the necessity, for prompt and trustworthy diagnostic procedures significantly fuels its popularity.


Market Size Forecast & Key Insights

2019
$422M2024
2029
$728M2034

Absolute Growth Opportunity = $306M

The 13c Urea market is projected to grow from $422.5 million in 2024 to $728 million in 2034. This represents a CAGR of 5.6%, reflecting rising demand across Breath Tests for Helicobacter Pylori, Agricultural Usage and Pharmaceutical Research.

The 13c Urea market is set to add $306 million between 2024 and 2034, with manufacturer targeting Research Activities & Pharmaceutical Manufacturing Application projected to gain a larger market share.

With Increasing diagnosis of gastrointestinal disorders, and Advancements in medical technology, 13c Urea market to expand 72% between 2024 and 2034.

Opportunities in the 13c Urea Market

Strategic Collaborations to Drive R&D

Collaborations between companies and academic institutions can drive advancements in research and development efforts concerning urea products. We may see the emergence of diagnostic methods, through these partnerships that could ultimately boost the growth of the 13Carbon urea market.

Untapped Potential in the Pharmaceutical Industry and Advancements in Medical Imaging

The increasing utilization of 13Carbon urea in the sector offers promising prospects for those involved in the industry as it finds considerable utility in medical diagnostics for identifying H. Pylori infection specifically. The integration of 13Carbon urea into diagnostic techniques could potentially result in higher financial gains, for the companies involved.

With ongoing progress in technology shaping the landscape of imaging practices today,the need for substances such as 13Carbon urea is rising due to their role, in producing detailed images of high quality. Through the exploration of imaging methods involving 13Carbon urea,there is a possibility of exploring market opportunities.

Growth Opportunities in North America and Asia-Pacific

Asia Pacific Outlook

The Asia Pacific region is showing potential as a market for 13Carbon Urea due to rising investments in healthcare infrastructure in countries like China and India. The progress in breath tests for identifying Helicobacter pylori infection has broadened 13Carbon Ureas applications in this region. A heightened understanding of 13Carbon Ureas usefulness, in healthcare is opening doors for manufacturers to grab a portion of the market share. While the market is competitive overall the key factors that drive competition are the production strategies and the quality of 13C urea.

North America Outlook

In the North American region, the use of 13c Urea has greatly accelerated, primarily driven by its significant role in healthcare applications. The innovative technologies in medical diagnostics have boosted the demand for 13c Urea, owing to its non-radioactive nature and high accuracy in diagnosing gastrointestinal disorders. A diverse range of opportunities exists in this region for manufacturers, as U. S. leads the medical diagnostic technology advancements. The competition in this region remains high with leading global players adopting advanced production methodologies to enhance the production of 13C Urea for various therapeutic applications. The need to continuously innovate and develop high-quality 13c Urea constitutes a prime driver of the market and competition in the region.

North America Outlook

In the North American region, the use of 13c Urea has greatly accelerated, primarily driven by its significant role in healthcare applications. The innovative technologies in medical diagnostics have boosted the demand for 13c Urea, owing to its non-radioactive nature and high accuracy in diagnosing gastrointestinal disorders. A diverse range of opportunities exists in this region for manufacturers, as U. S. leads the medical diagnostic technology advancements. The competition in this region remains high with leading global players adopting advanced production methodologies to enhance the production of 13C Urea for various therapeutic applications. The need to continuously innovate and develop high-quality 13c Urea constitutes a prime driver of the market and competition in the region.

Asia-Pacific Outlook

The Asia Pacific region is showing potential as a market for 13Carbon Urea due to rising investments in healthcare infrastructure in countries like China and India. The progress in breath tests for identifying Helicobacter pylori infection has broadened 13Carbon Ureas applications in this region. A heightened understanding of 13Carbon Ureas usefulness, in healthcare is opening doors for manufacturers to grab a portion of the market share. While the market is competitive overall the key factors that drive competition are the production strategies and the quality of 13C urea.

Growth Opportunities in North America and Asia-Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, China, Japan, India are expected to grow at 3.6% to 5.4% CAGR

2

Emerging Markets : Brazil, India, South Africa are expected to grow at 6.4% to 7.7% CAGR

Market Analysis Chart

The way that things are going in the 13C Urea market has been greatly affected by factors that play a role in thisindustry'soperations. One key factor pushing up demand for 13C Urea is its increasing use in healthcare applications like diagnostics. Its non radioactive properties and its involvement in tests like Breath Test, for identifying Helicobacter pylori. A bacteria connected to stomach ulcers and cancers. Showcase how valuable this product can be.

Recent Developments and Technological Advancement

December 2024

PharmaTech has increased its production capabilities, for 13C urea to meet the rising demand.

November 2024

BioSolution Inc launched an upgraded iteration of 13C Urea tailored for the sector to strengthen its position, in the market further.

October 2024

Advanced MedTech introduced a line of diagnostic kits that make use of 13C Urea as part of their move, towards offering cutting edge healthcare solutions.

In the stage of affairs the popularity of 13C Urea has been steadily increasing due to the use of new methods and technologies. This upward pattern doesnt just show advancements in healthcare. Also highlights the growing need for non invasive diagnostic options, which are a key application, for 13C Urea.

Impact of Industry Transitions on the 13c Urea Market

As a core segment of the Specialty Chemicals industry, the 13c Urea market develops in line with broader industry shifts. Over recent years, transitions such as Automation in Testing and Research in Agriculture have redefined priorities across the Specialty Chemicals sector, influencing how the 13c Urea market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Automation in Testing:

There has been a progress in the use of 13C urea in breath tests with the integration of automation technology being a key factor behind this advancement; leading to improved efficiency and accuracy while minimizing human mistakes. These enhancements have resulted in an increased need for 13C urea due to its nature and its essential role in these tests. The pharmaceutical and healthcare industries are experiencing a rise in demand, for diagnostic tools and patient care solutions as a result of this technological evolution.

2

Research in Agriculture:

13C urea is increasingly playing a role in agricultural studies nowadays as it is utilized for assessing soil fertility levels and determining the nutrient requirements of crops and the effectiveness of fertilizers in farming practices with a sustainable approach in mind. For instance; the utilization of this isotope aids in measuring the decomposition of soil matter which is a crucial element in sustainable agricultural practices. Therefore; the growing trend towards farming methods has led to a notable rise in the demand, for 13C urea thereby impacting the agricultural industry significantly. The outcome is a market that holds promise for expansion, in both well established and up and coming economies.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Specialty Chemicals industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Specialty Chemicals industry cascade into the 13c Urea market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increasing Diagnosis of Gastrointestinal Disorders, and Integration of Precision Medicine

The significant increase in detecting digestive system issues like stomach ulcers has also created a thriving market for 13C Urea testing kits. The 13C Urea breath test has also become increasingly sought after for diagnosing Helicobacter pylori due, to a growing number of conditions worldwide.
The advancements in precision medicine have also opened up avenues for personalized treatment approaches and are also driving significant growth opportunities for 13C Urea as well. The strategic utilization of 13C Urea in tailored treatments is also particularly evident in its role in non invasive diagnostics and the monitoring of treatment effectiveness, in gastric illnesses—a key segment poised for market growth.
Advancements in technology have also played a crucial role in driving growth in the 13C Urea market by introducing non invasive diagnostic methods like 13C Urea breath tests, for detecting Helicobacter pylori infections accurately and safely without invasive procedures commonly seen before.

Restraint: Regulatory Compliance Hurdles

In the 13th century urea sector industry faces a hurdle in meeting strict regulatory standards. Businesses are required to follow guidelines and rules established by governmental and international bodies to guarantee the safety and effectiveness of their goods. The rigorous packaging regulations, environmental standards and product testing criteria increase production costs. Could lead to delays, in launching products into the market. This could potentially hinder market growth. Impact demand dynamics.

Challenge: High Pricing and Accessibility Concerns

One major challenge faced by the 13C Urea industry is its pricing that restricts access, for lower income and emerging markets despite its wide range of uses and applications.

Supply Chain Landscape

Raw Material Acquisition

Sigma Aldrich

Chemotech Ltd

Processing & Production

Cambridge Isotope Laboratories

Ningbo Happy Biotechnology

Product Assembly
IsoLife / Medical Isotopes Inc
Distribution & Retail
Englewood Hospital / Rockwood Clinics
Raw Material Acquisition

Sigma Aldrich

Chemotech Ltd

Processing & Production

Cambridge Isotope Laboratories

Ningbo Happy Biotechnology

Product Assembly

IsoLife

Medical Isotopes Inc

Distribution & Retail

Englewood Hospital

Rockwood Clinics

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Helicobacter Pylori Diagnosis
Healthcare and Medical
Macherey-Nagel
Enhancing diagnostic accuracy through technological advancements in 13c Urea breath tests.
Cancer Research
Biomedical Research
Sigma-Aldrich
Investing in R&D to innovate methods for 13c Urea incorporation in cancer cell studies.
Agriculture Developments
Agricultural Sciences
Cambridge Isotope Laboratories
Strategizing toward improved cultivation techniques using 13c Urea in soil-nitrogen studies.
Drug Metabolism Studies
Pharmaceuticals
Isotec
Focusing on enhancing drug discovery processes via 13c Urea metabolic pathway analysis.

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the 13c Urea market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of 13c Urea in Pharmaceutical Research and Agricultural Usage and Breath Tests for Helicobacter Pylori

Pharmaceutical Research and Agricultural Usage

In research labs like those of Merck and Pfizer; 13C Urea finds an alternate use as a tracer, for studying metabolic processes in pharmacokinetics without causing harm to the subjects involved since the non radioactive isotope takes the place of regular urea in metabolic pathways for detailed analysis; this unique capability is valued for monitoring metabolic processes in real time during drug development and clinical trials.

13 carbon urea is also utilized in the sector as a tracer isotope for studying nitrogen cycles – aiding in assessing how crops utilize nitrogen from fertilizers and the loss of nitrogen, from the soil.

Breath Tests for Helicobacter Pylori

in medical diagnostics is where 13C Urea finds its main application. Particularly in breath assessments meant for spotting the existence of Helicobacter pylori bacteria associated with stomach ulcers. The 13C tagged urea gets consumed along, with a meal; any Helicobacter pylori present breaks down the isotope. Releases it as carbon dioxide through exhalation. This process can be identified using either a mass spectrometer or an infrared spectrometer. Otsuka Pharmaceutical and DiagnOptics are players, in the field of diagnostics. They excel in breath tests that make use of the distinctive characteristics of 13C Urea.

13c Urea vs. Substitutes:
Performance and Positioning Analysis

Compared to its alternatives, 13c Urea offers a non-radioactive, safe and highly effective method for diagnosing H. pylori infections. Its unique market position lies in its expanding usage in gastroenterology worldwide and potential for high market growth. These Alternatives specially Breath Ketone Analyzer Devices has experienced a rapid growth as detailed in our latest report.

13c Urea
  • Breath Ketone Analyzer Devices /
  • Pyruvic acid
    High accuracy, Non-radioactive nature
    Limited availability, High cost
    Non-radioactive, widely available
    Expensive, less accurate detection methods

13c Urea vs. Substitutes:
Performance and Positioning Analysis

13c Urea

  • High accuracy, Non-radioactive nature
  • Limited availability, High cost

Breath Ketone Analyzer Devices / Pyruvic acid

  • Non-radioactive, widely available
  • Expensive, less accurate detection methods

Compared to its alternatives, 13c Urea offers a non-radioactive, safe and highly effective method for diagnosing H. pylori infections. Its unique market position lies in its expanding usage in gastroenterology worldwide and potential for high market growth. These Alternatives specially Breath Ketone Analyzer Devices has experienced a rapid growth as detailed in our latest report.

Loading...

Research Methodology

This market research methodology defines the 13c Urea market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at macro and micro levels. As part of the Specialty Chemicals ecosystem, we analyze 13c Urea across Hospitals, Research Institutes, and Pharmaceutical Companies Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.



Key Sources Referenced:


We benchmark competitors such as Helicobacter Test INFAI, Otsuka Pharmaceutical Factory, and Urea Breath Test Kit HCBT by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Acquisition, Processing & Production, and Product Assembly. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Specialty Chemicals revenues to estimate the 13c Urea segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Acquisition (Sigma Aldrich, Chemotech Ltd), Processing & Production (Cambridge Isotope Laboratories, Ningbo Happy Biotechnology), and Product Assembly. Our parallel substitute analysis examines Breath Ketone Analyzer Devices and Pyruvic acid, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Helicobacter Test INFAI, Otsuka Pharmaceutical Factory, and Urea Breath Test Kit HCBT, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the 13c Urea market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

13c Urea Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 446 million
Revenue Forecast in 2034USD 728 million
Growth RateCAGR of 5.6% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024422 million
Growth OpportunityUSD 306 million
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD million and Industry Statistics
Market Size 2024422 million USD
Market Size 2027497 million USD
Market Size 2029554 million USD
Market Size 2030585 million USD
Market Size 2034728 million USD
Market Size 2035769 million USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Type, Application, End-User Sectors, Technology Platforms, Distribution Channels
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledHelicobacter Test INFAI, Otsuka Pharmaceutical Factory, Urea Breath Test Kit HCBT, Kibion Diagnostics, Exalenz Bioscience, Beijing Richen-Force, BreathID Hp, Isodiagnostika, BreathMatix, UCBT, Medline Industries and Laboratory Corporation of America Holdings
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

13c Urea Market Size, Opportunities & Strategic Insights, by Product Type

4.1Powder
4.2Tablet
Chapter 5

13c Urea Market Size, Opportunities & Strategic Insights, by Application

5.1Diagnostic Tests
5.2Research Activities
5.3Pharmaceutical Manufacturing
5.4Others
Chapter 6

13c Urea Market Size, Opportunities & Strategic Insights, by End-User Sectors

6.1Hospitals
6.2Research Institutes
6.3Pharmaceutical Companies
6.4Others
Chapter 7

13c Urea Market Size, Opportunities & Strategic Insights, by Technology Platforms

7.1Breath Test Technologies
7.2Biochemical Analysis
Chapter 8

13c Urea Market Size, Opportunities & Strategic Insights, by Distribution Channels

8.1Pharmaceutical Distributors
8.2Medical Stores
8.3Online Sales
Chapter 9

13c Urea Market, by Region

9.1North America 13c Urea Market Size, Opportunities, Key Trends & Strategic Insights
9.1.1U.S.
9.1.2Canada
9.2Europe 13c Urea Market Size, Opportunities, Key Trends & Strategic Insights
9.2.1Germany
9.2.2France
9.2.3UK
9.2.4Italy
9.2.5The Netherlands
9.2.6Rest of EU
9.3Asia Pacific 13c Urea Market Size, Opportunities, Key Trends & Strategic Insights
9.3.1China
9.3.2Japan
9.3.3South Korea
9.3.4India
9.3.5Australia
9.3.6Thailand
9.3.7Rest of APAC
9.4Middle East & Africa 13c Urea Market Size, Opportunities, Key Trends & Strategic Insights
9.4.1Saudi Arabia
9.4.2United Arab Emirates
9.4.3South Africa
9.4.4Rest of MEA
9.5Latin America 13c Urea Market Size, Opportunities, Key Trends & Strategic Insights
9.5.1Brazil
9.5.2Mexico
9.5.3Rest of LA
9.6CIS 13c Urea Market Size, Opportunities, Key Trends & Strategic Insights
9.6.1Russia
9.6.2Rest of CIS
Chapter 10

Competitive Landscape

10.1Competitive Dashboard & Market Share Analysis
10.2Company Profiles (Overview, Financials, Developments, SWOT)
10.2.1Helicobacter Test INFAI
10.2.2Otsuka Pharmaceutical Factory
10.2.3Urea Breath Test Kit HCBT
10.2.4Kibion Diagnostics
10.2.5Exalenz Bioscience
10.2.6Beijing Richen-Force
10.2.7BreathID Hp
10.2.8Isodiagnostika
10.2.9BreathMatix
10.2.10UCBT
10.2.11Medline Industries
10.2.12Laboratory Corporation of America Holdings